mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.2 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.2 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |